AzTrials
AzTrials

Cardiac SurgeryNCT07189026

Prevalence and Clinical Impact of Airway Opening Pressure in Post-Cardiac Surgery Patients

A study testing Airway opening pressure in people with Cardiac Surgery and Mechanical Ventilation After Surgery, run by Laval University at 1 site in Canada.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Airway opening pressure is a key parameter in assessing respiratory mechanics. Current practice primarily relies on indirect assessments of lung mechanics, but growing evidence suggests that direct airway opening pressure measurement could enhance individualized ventilatory strategies. Read more about this study

Who is it for?
Ages 18 months and older
What is being tested?
Airway opening pressure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
196 participants
Where
1 siteCanada
Study dates
27 Jun 2025to Jun 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 months and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Adult (≥18 years)
  • Undergoing elective coronary artery bypass grafting (CABG) or valve surgery, or combined procedures with expected postoperative mechanical ventilation

Who cannot join

  • Patient receiving invasive mechanical ventilation prior to surgery

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval

    Québec, Quebec

Other trials in Canada

About this study

Official title: Prevalence and Clinical Impact of Airway Opening Pressure in Post-Cardiac Surgery Patients: A Prospective Observational Study

Airway opening pressure is a key parameter in assessing respiratory mechanics. Current practice primarily relies on indirect assessments of lung mechanics, but growing evidence suggests that direct airway opening pressure measurement could enhance individualized ventilatory strategies. Significant airway opening pressure suggests incomplete alveolar recruitment at end-expiration, which may contribute to ventilation-perfusion mismatch, increased respiratory effort, and postoperative pulmonary complications such as atelectasis and impaired gas exchange. Determining the prevalence and clinical relevance of significant airway opening pressure in post-cardiac surgery patients could contribute to more personalized respiratory strategies and improve postoperative care.

Being tested
Airway opening pressure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Airway opening pressureDiagnostic test

    Airway opening pressure will be measured within one hour of intensive care unit admission (using a standardized low-flow insufflation maneuver flow 5-6 LPM). The inflection point on the pressure-time or pressure-volume waveform- depending on ventilator model-will define the airway opening pressure.

Study groups in NCT07189026
Study groupRoleWhat they receive
Post operative cardiac surgeryOtherNot described
Receives: Diagnostic Test: Airway opening pressure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prevalence of significant airway opening pressure

    airway opening pressure ≥ 5 cmH₂O

    Measured: up to 1 hour after intensive care admission

Secondary outcomes (13)
  1. Airway opening pressure prevalence based on body mass index

    Airway opening pressure prevalence base on Obesity status (body mass index ≥30 vs. <30 kg/m²)

    Measured: up to 1 hour

  2. Airway opening pressure prevalence based on cardiopulmonary bypass duration

    Airway opening pressure prevalence based on cardiopulmonary bypass duration (minutes)

    Measured: up to 1 hour

  3. Airway opening pressure prevalence based on left ventricular dysfunction

    Airway opening pressure prevalence based on left ventricular dysfunction (Ieft ventricular ejection fraction < 50 percent vs > 50 percent)

    Measured: up to 1 hour

  4. Airway opening pressure prevalence based on inotropic support

    Airway opening pressure prevalence based on use of amines (< 0.1 mcg/kg/min or norepinephrine equivalent vs > 0.1 mcg/kg/min or norepinephrine equivalent)

    Measured: up to 1 hour

  5. Airway opening pressure prevalence based on age

    Airway opening pressure prevalence base on age

    Measured: up to 1 hour

  6. Airway opening pressure prevalence based on intraoperative fluid balance

    Airway opening pressure prevalence base on intraoperative fluid balance

    Measured: up to 1 hour

  7. Feasibility of airway opening pressure measurement

    proportion of patients in whom the maneuver is successfully completed

    Measured: up to 1 hour

  8. Positive end expiratory pressure level

    Number of times Positive end expiratory pressure is set greater than measured airway opening pressure

    Measured: up to 1 hour

  9. Extubation

    Correlation between airway opening pressure and time to extubation

    Measured: Day7

  10. Patient position

    Comparison of airway opening pressure values in flat versus semi-recumbent (30-degree) positions

    Measured: up to 1 hour

  11. Hemodynamic tolerance base on blood pressure drop

    Evaluation of hemodynamic tolerance based on arterial pressure during positive end-expiratory pressure adjustment (if inotropic agents are required, an increase of more than 0.05 mcg/kg/min in norepinephrine equivalent is considered significant)

    Measured: up to 15 minutes

  12. Hemodynamic tolerance base on pulse oxygen saturation drop

    Evaluation of hemodynamic tolerance based on pulse oxygen saturation. A decrease in pulse oxygen saturation of 5 percent from baseline or more is considered significant.

    Measured: up to 15 minutes

  13. Non-interruptive airway opening pressure measurement method

    The novel non-interruptive airway opening pressure measurement method will be validated

    Measured: up to 1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Sep 2025
  2. Study start27 Jun 2025
  3. Primary completionDec 2027 (estimated)
  4. Study completionJun 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
196 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07189026
Sponsor's protocol ID
2026-4399
Status last verified
Nov 2026
First submitted
27 Aug 2025
Last updated
5 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Airway opening pressure in people with Cardiac Surgery and Mechanical Ventilation After Surgery, run by Laval University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 5 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prevalence of significant airway opening pressure (time frame: up to 1 hour after intensive care admission). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Nov 2026; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in